Identification of treatment-resistant major depressive disorder using a machine learning algorithm

被引：0
|
作者：
Semeniuta, Daniel [1 ]
Marci, Carl [1 ]
Bandaria, Jigar [1 ]
Zabinski, Joseph W. [1 ]
Paulus, Jessica K. [1 ]
Orsini, Lucinda [2 ]
Boussios, Costas [1 ]
机构：
[1] OM1 Inc, Boston, MA USA
[2] Compass Pathways Ltd, London, England
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
956
引用
收藏
页码：447 / 447
页数：1
相关论文
共 50 条
  • [41] Moderate physical exercise and quality of life in patients with treatment-resistant major depressive disorder
    Mota-Pereira, Jorge
    Carvalho, Serafim
    Silverio, Jorge
    Fonte, Daniela
    Pizarro, Andreia
    Teixeira, Joana
    Ribeiro, Jose Carlos
    Ramos, Joaquim
    JOURNAL OF PSYCHIATRIC RESEARCH, 2011, 45 (12) : 1657 - 1659
  • [42] Choosing death in depression: a commentary on 'Treatment-resistant major depressive disorder and assisted dying'
    Broome, Matthew R.
    de Cates, Angharad
    JOURNAL OF MEDICAL ETHICS, 2015, 41 (08) : 586 - 587
  • [43] Mirtazapine Combination in Treatment-Resistant Major Depressive Disorder: A Retrospective Evaluation of Six Weeks
    Aydemir, Omer
    Deveci, Artuner
    Taskin, E. Oryal
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 19 (04): : 347 - 352
  • [44] Psychiatric Comorbidity as a predictor of clinical response to nortriptyline in treatment-resistant major depressive disorder
    Papakostas, GI
    Petersen, TJ
    Farabaugh, AH
    Murakami, JL
    Pava, JA
    Alpert, JE
    Fava, M
    Nierenberg, AA
    JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (11) : 1357 - 1361
  • [45] Transformative Therapies for Depression: Postpartum Depression, Major Depressive Disorder, and Treatment-Resistant Depression
    Richardson, Elizabeth
    Patterson, Riah
    Meltzer-Brody, Samantha
    Mcclure, Robert
    Tow, Amanda
    ANNUAL REVIEW OF MEDICINE, 2025, 76 : 81 - 93
  • [46] Olanzapine/FluoxetineA Review of its Use in Patients With Treatment-Resistant Major Depressive Disorder
    Jamie D. Croxtall
    Lesley J. Scott
    CNS Drugs, 2010, 24 : 245 - 262
  • [47] A narrative review of digital biomarkers in the management of major depressive disorder and treatment-resistant forms
    Vignapiano, Annarita
    Monaco, Francesco
    Pagano, Claudio
    Piacente, Martina
    Farina, Federica
    Petrillo, Gianvito
    Sica, Raffaella
    Marenna, Alessandra
    Shin, Jae Il
    Solmi, Marco
    Corrivetti, Giulio
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [48] Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder
    Papakostas, GI
    Petersen, TJ
    Kinrys, G
    Burns, AM
    Worthington, JJ
    Alpert, JE
    Fava, M
    Nierenberg, AA
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (10) : 1326 - 1330
  • [49] Olanzapine/Fluiloxietine A Review of its Use in Patients With Treatment-Resistant Major Depressive Disorder
    Croxtall, Jamie D.
    Scott, Lesley J.
    CNS DRUGS, 2010, 24 (03) : 245 - 262
  • [50] The Prevalence and National Burden of Treatment-Resistant Depression and Major Depressive Disorder in the United States
    Zhdanava, Maryia
    Pilon, Dominic
    Ghelerter, Isabelle
    Chow, Wing
    Joshi, Kruti
    Lefebvre, Patrick
    Sheehan, John J.
    JOURNAL OF CLINICAL PSYCHIATRY, 2021, 82 (02)
12345